高级检索
当前位置: 首页 > 详情页

GSPE alleviates renal fibrosis by inhibiting the activation of C3/HMGB1/TGF-β1 pathway

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Nephrol,Div Internal Med, Wuhan, Hubei, Peoples R China [2]Huazhong Univ Sci & Technol, Hubei Canc Hosp, Tongji Med Coll, Wuhan, Peoples R China
出处:
ISSN:

关键词: GSPE Complement component 3 (C3) HMGB1 TGF-beta 1 Renal fibrosis

摘要:
Grape seed proanthocyanidin extract (GSPE) has been reported to exhibit a variety of protective effects, such as antioxidant, anti-atherosclerosis and other pharmacological effects. As a member of the complement system, complement component 3 (C3) deposition in the glomerulus is recognized as an important causative mediator of various kidney diseases. In this study, we aimed to identify the effect of GSPE on C3 in the chronic kidney fibrosis and evaluate the possible mechanism. We observed that administration of GSPE relieves inflammation and chronic renal fibrosis in mouse models of UUO. GSPE inhibited C3 secreted by macrophages to relieve renal interstitial inflammation. In vitro, we found that C3 stimulated HMGB1 translocation form nucleus to cytoplasm and promote the expression of pro-inflammatory cytokines including TGF-beta 1 in primary renal tubular epithelial cells (PTEC), which could be inhibited by GSPE. Meanwhile, GSPE could also decreased HMGB1-induced EMT of PTEC through suppresses the HMGB1/TLR4/p65/TGF-beta 1 pathway. In addition, the myofibroblast activation was inhibited by GSPE via TGF-beta 1/Smad2/3 signaling pathways in normal rat kidney fibroblast (NRK-49F) cells. Overall, these observations provide that GSPE alleviates renal fibrosis by inhibiting the C3/HMGB1/TGF-beta 1 pathway and could thus lead to find the potential therapy for the suppression of renal fibrosis.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 3 区 生物
小类 | 2 区 毒理学 3 区 生化与分子生物学 3 区 药学
最新[2025]版:
大类 | 2 区 医学
小类 | 1 区 毒理学 2 区 生化与分子生物学 2 区 药学
JCR分区:
出版当年[2018]版:
Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Q2 PHARMACOLOGY & PHARMACY Q2 TOXICOLOGY
最新[2023]版:
Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Q1 PHARMACOLOGY & PHARMACY Q1 TOXICOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者单位: [1]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Nephrol,Div Internal Med, Wuhan, Hubei, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:428 今日访问量:1 总访问量:411 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)